尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Xu Yuan, Director. Insider active across 3 companies, notably Akero Therapeutics, Inc.. Aggregated, 18 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €22k. Activity tracked since 3 August 2021. The latest transaction was filed on 4 May 2026 (Purchase). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 条申报中的 18 条
Xu Yuan serves as a Director at Akero Therapeutics, Inc., FATE THERAPEUTICS INC, and IGG Inc. With significant experience in the biopharmaceutical sector, he contributes to the strategic direction and governance of these companies. His role involves overseeing operations and evaluating company performance while ensuring shareholder interests are upheld. Xu Yuan is recognized for his expertise in product development and risk management, allowing him to add value to each organization he is involved with.